Whanin makes a leap to be an advancing company
that leads a healthy society,
| Code | Target Disease | Exploration | Research | Preclinical | Clinical Phase 1 |
Clinical Phase 2 |
Clinical Phase 3 |
Drug Approval |
|---|---|---|---|---|---|---|---|---|
| WIL-1901 | Dementia |
|
||||||
| WIP-2401 | Depression |
|
||||||
| WIT-2001 | Parkinson’s |
|
||||||
| WIL-1903 | Alcohol Dependence |
|
||||||
| WIE-2301 | Essential hypertension |
|
||||||
| WIE-2302 | Essential hypertension |
|
||||||
| WIE-2303 | Gastric ulcer |
|
||||||
| WIG-2202 | Epilepsy |
|
||||||
| WIG-2401 | ADHD |
|
||||||
| WIG-2404 | Depression |
|
||||||
| WIF-2401 | Cognitive dysfunction syndrome |
|
